KUALA LUMPUR: UCrest Bhd has made its foray into the respiratory medical centres in the United States with iMefic technology amid the Covid-19 pandemic.
The respiratory centres are commonly known as sleep centres or sleep clinics in the US.
UCrest, in a statement today, claimed that iMedic was the leading platform for online medical services.
Under the platform, UCrest said doctors can provide online medical consultation and management based on the uploaded vital signs from patient's connected medical devices and symptoms recorded.
iMedicTM can be wirelessly connected with several leading brands of continuous positive airway pressure (CPAP) ventilators where patients can be managed remotely, it added.
The technology is used by respiratory centres for managing the virus infected as well as the regular chronic respiratory patients.
"This pandemic has put a constraint on the face to face clinical visit and has caused a soaring demand of online medical services for the regular chronic disease patients," UCrest chairman and chief executive officer Eg Kah Yee said.
The company expects to see an accelerated pace in adoption of the technology not just in the respiratory market but other chronic disease management market in the US.
"We expect the US market to be a significant revenue contributor in the near future," Eg said in the statement.
The current market size of sleep disorders, a common respiratory disease in the US was estimated to be north of US$8 billion, according to UCrest.
It is reported that between 50 million and 70 million Americans had chronic sleep disorders where patients' breathing stops and starts repeatedly and snore loudly.
UCrest said Covid-19 had caused an exponential new demand for acute respiratory treatment in addition to the chronic sleep disorders market.
"This is awesome technology and it is definitely the way to go," Snooze Laboratories Massachusetts chief executive officer Jason Metcalfeb was quoted in the statement.
"Yes, not only that we want to use this for the respiratory patients, but also other chronic patients as well," said Delaware Sleep Disorder Centres chief executive officer Lyron Deputy.
"It will keep doctors and nurses safe in a pandemic like Covid-19," he added.